Pneumonia Market Insights, Epidemiology, and Market Forecast – 2030

April 06 13:47 2020
Pneumonia Market Insights, Epidemiology, and Market Forecast - 2030

DelveInsight has launched a new report on Pneumonia Market Insights, Epidemiology and Market Forecast-2030

DelveInsight’s “Pneumonia – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Pneumonia, historical and forecasted epidemiology as well as the Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Pneumonia market report provides current treatment practices, emerging drugs, Pneumonia market share of the individual therapies, current and forecasted Pneumonia market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Pneumonia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

According to the National Foundation for Infectious Diseases, Pneumococcal disease (PD) is an infection caused by bacteria called Streptococcus pneumoniae or pneumococcus.Streptococcus pneumoniae is transmitted mainly through respiratory droplets and colonizes the nasopharynx. Infection of other parts of the body, resulting in disease, occur through direct spread or invasion of the bloodstream.Pneumococcal infections may be local or invasive. There are about 90 types of Streptococcus pneumoniae that cause a range of symptoms from relatively minor to very serious. Some types are more likely to cause infections in particular parts of the body than others, such as the sinuses and ear.

 

Request for :- free sample page

Epidemiology

The Pneumonia epidemiology division provide insights about historical and current Pneumonia patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Report Key facts:- 

1. As per the study by Zhang et al. titled “Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study,” the incidence of invasive pneumococcal disease (IPD) was 3.62/100,000 person-years. Rate of IPD for adults with one at-risk condition was 3.7 times higher than healthy adults but 10.6 times higher for adults with ≥2 at-risk conditions.

 2. The study conducted by Zhang et al. shows that adults with chronic lung disease were at the greatest risk of IPD as compared to healthy adults. The risk of IPD in adults with chronic liver disease was 7.2 times the risk in healthy adults, followed by chronic heart disease, diabetes mellitus, and asthma. The risk of IPD in adults with HIV was 17.4 times the risk in healthy adults, followed by asplenia, cancer, and organ transplant.

According to Zhang et al., the rate per 100,000 person-years was 1.77 for people of ages 19–49 years and 6.63 for people of ages 50–64 years”

Key companies are working on Pneumonia disease that are given below:- 

1.  Merck Pharma Co. 

2. Pfizer Pharma Co 

3. Astellas Pharma Co 

Name of drugs covered are given below:- 

1. V114

2. 20vPNC

3. ASP3772

Table of contents

1. Key Insights

2. Executive Summary of Pneumonia

3. Competitive Intelligence Analysis for Pneumonia

4. Pneumonia: Market Overview at a Glance

4.1. Pneumonia Total Market Share (%) Distribution in 2017

4.2. Pneumonia Total Market Share (%) Distribution in 2030

5. Pneumonia: Disease Background and Overview

6. Patient Journey

7. Pneumonia Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Pneumonia Treatment and Management

8.2. Pneumonia Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Pneumonia Treatment

11. Marketed Products

12. Emerging Therapies

13. Pneumonia: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Pneumonia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Pneumonia market
  • To understand the future market competition in the Pneumonia market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Pneumonia in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Pneumonia market
  • To understand the future market competition in the Pneumonia market

Related Reports:-

1. Pneumonia – Epidemiology Forecast to 2030

2. Bacterial Pneumonia – Pipeline Insights, 2020

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

  Categories: